1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

C215H220B3Br2F3N26O13 — CID 161415040

IUPAC1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESC.C.C.C.C.C.C.CC(C)CC(=O)Cc1cncc(Br)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3c(c2)c(-c2nc4c(-c5cccc(F)c5)cncc4[nH]2)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3c(c2)c(C=O)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)c1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3c(c2)c(C=O)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)OC1(C)C.Nc1cncc(-c2cccc(F)c2)c1N.O=Cc1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c2ccc(Br)cc12
InChIInChI=1S/C48H38FN7O.C37H32N4O2.C33H31BN2O3.C29H24FN7O.C27H19BrN2O.C12H24B2O4.C11H14BrNO.C11H10FN3.7CH4/c1-31(2)23-44(57)52-39-25-34(27-50-28-39)32-21-22-43-40(26-32)46(47-53-42-30-51-29-41(45(42)54-47)33-13-12-20-38(49)24-33)55-56(43)48(35-14-6-3-7-15-35,36-16-8-4-9-17-36)37-18-10-5-11-19-37;1-26(2)20-36(43)39-32-21-28(23-38-24-32)27-18-19-35-33(22-27)34(25-42)40-41(35)37(29-12-6-3-7-13-29,30-14-8-4-9-15-30)31-16-10-5-11-17-31;1-31(2)32(3,4)39-34(38-31)27-20-21-30-28(22-27)29(23-37)35-36(30)33(24-14-8-5-9-15-24,25-16-10-6-11-17-25)26-18-12-7-13-19-26;1-16(2)8-26(38)33-21-10-19(12-31-13-21)17-6-7-24-22(11-17)28(37-36-24)29-34-25-15-32-14-23(27(25)35-29)18-4-3-5-20(30)9-18;28-23-16-17-26-24(18-23)25(19-31)29-30(26)27(20-10-4-1-5-11-20,21-12-6-2-7-13-21)22-14-8-3-9-15-22;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-8(2)3-11(14)5-9-4-10(12)7-13-6-9;12-8-3-1-2-7(4-8)9-5-15-6-10(13)11(9)14;;;;;;;/h3-22,24-31H,23H2,1-2H3,(H,52,57)(H,53,54);3-19,21-26H,20H2,1-2H3,(H,39,43);5-23H,1-4H3;3-7,9-16H,8H2,1-2H3,(H,33,38)(H,34,35)(H,36,37);1-19H;1-8H3;4,6-8H,3,5H2,1-2H3;1-6H,13H2,(H2,14,15);7*1H4
InChIKeyVVYWQNZKGARMLD-UHFFFAOYSA-N
MW3625.53 g/mol
LogP48.95
Rot. Bonds42

About 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (PubChem CID 161415040) has the molecular formula C215H220B3Br2F3N26O13 and a molecular weight of 3625.53 g/mol. Its IUPAC name is 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.

Molecular Properties

Compound Name1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
PubChem CID161415040
Molecular FormulaC215H220B3Br2F3N26O13
Molecular Weight3625.53 g/mol
Exact Mass3621.60
IUPAC Name1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESC.C.C.C.C.C.C.CC(C)CC(=O)Cc1cncc(Br)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3c(c2)c(-c2nc4c(-c5cccc(F)c5)cncc4[nH]2)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3c(c2)c(C=O)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)c1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3c(c2)c(C=O)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)OC1(C)C.Nc1cncc(-c2cccc(F)c2)c1N.O=Cc1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c2ccc(Br)cc12
InChIInChI=1S/C48H38FN7O.C37H32N4O2.C33H31BN2O3.C29H24FN7O.C27H19BrN2O.C12H24B2O4.C11H14BrNO.C11H10FN3.7CH4/c1-31(2)23-44(57)52-39-25-34(27-50-28-39)32-21-22-43-40(26-32)46(47-53-42-30-51-29-41(45(42)54-47)33-13-12-20-38(49)24-33)55-56(43)48(35-14-6-3-7-15-35,36-16-8-4-9-17-36)37-18-10-5-11-19-37;1-26(2)20-36(43)39-32-21-28(23-38-24-32)27-18-19-35-33(22-27)34(25-42)40-41(35)37(29-12-6-3-7-13-29,30-14-8-4-9-15-30)31-16-10-5-11-17-31;1-31(2)32(3,4)39-34(38-31)27-20-21-30-28(22-27)29(23-37)35-36(30)33(24-14-8-5-9-15-24,25-16-10-6-11-17-25)26-18-12-7-13-19-26;1-16(2)8-26(38)33-21-10-19(12-31-13-21)17-6-7-24-22(11-17)28(37-36-24)29-34-25-15-32-14-23(27(25)35-29)18-4-3-5-20(30)9-18;28-23-16-17-26-24(18-23)25(19-31)29-30(26)27(20-10-4-1-5-11-20,21-12-6-2-7-13-21)22-14-8-3-9-15-22;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-8(2)3-11(14)5-9-4-10(12)7-13-6-9;12-8-3-1-2-7(4-8)9-5-15-6-10(13)11(9)14;;;;;;;/h3-22,24-31H,23H2,1-2H3,(H,52,57)(H,53,54);3-19,21-26H,20H2,1-2H3,(H,39,43);5-23H,1-4H3;3-7,9-16H,8H2,1-2H3,(H,33,38)(H,34,35)(H,36,37);1-19H;1-8H3;4,6-8H,3,5H2,1-2H3;1-6H,13H2,(H2,14,15);7*1H4
InChIKeyVVYWQNZKGARMLD-UHFFFAOYSA-N
XLogP48.95
TPSA510.55 Ų
H-Bond Donors8
H-Bond Acceptors33
Rotatable Bonds42
Heavy Atoms262
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003625.53
LogP ≤ 548.95
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The IUPAC name of 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (CID 161415040) is 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.
What is the SMILES notation for 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The canonical SMILES for 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is C.C.C.C.C.C.C.CC(C)CC(=O)Cc1cncc(Br)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3c(c2)c(-c2nc4c(-c5cccc(F)c5)cncc4[nH]2)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)c1.CC(C)CC(=O)Nc1cncc(-c2ccc3c(c2)c(C=O)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)c1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3c(c2)c(C=O)nn3C(c2ccccc2)(c2ccccc2)c2ccccc2)OC1(C)C.Nc1cncc(-c2cccc(F)c2)c1N.O=Cc1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c2ccc(Br)cc12.
What is the InChIKey of 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The InChIKey is VVYWQNZKGARMLD-UHFFFAOYSA-N. The full InChI is InChI=1S/C48H38FN7O.C37H32N4O2.C33H31BN2O3.C29H24FN7O.C27H19BrN2O.C12H24B2O4.C11H14BrNO.C11H10FN3.7CH4/c1-31(2)23-44(57)52-39-25-34(27-50-28-39)32-21-22-43-40(26-32)46(47-53-42-30-51-29-41(45(42)54-47)33-13-12-20-38(49)24-33)55-56(43)48(35-14-6-3-7-15-35,36-16-8-4-9-17-36)37-18-10-5-11-19-37;1-26(2)20-36(43)39-32-21-28(23-38-24-32)27-18-19-35-33(22-27)34(25-42)40-41(35)37(29-12-6-3-7-13-29,30-14-8-4-9-15-30)31-16-10-5-11-17-31;1-31(2)32(3,4)39-34(38-31)27-20-21-30-28(22-27)29(23-37)35-36(30)33(24-14-8-5-9-15-24,25-16-10-6-11-17-25)26-18-12-7-13-19-26;1-16(2)8-26(38)33-21-10-19(12-31-13-21)17-6-7-24-22(11-17)28(37-36-24)29-34-25-15-32-14-23(27(25)35-29)18-4-3-5-20(30)9-18;28-23-16-17-26-24(18-23)25(19-31)29-30(26)27(20-10-4-1-5-11-20,21-12-6-2-7-13-21)22-14-8-3-9-15-22;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-8(2)3-11(14)5-9-4-10(12)7-13-6-9;12-8-3-1-2-7(4-8)9-5-15-6-10(13)11(9)14;;;;;;;/h3-22,24-31H,23H2,1-2H3,(H,52,57)(H,53,54);3-19,21-26H,20H2,1-2H3,(H,39,43);5-23H,1-4H3;3-7,9-16H,8H2,1-2H3,(H,33,38)(H,34,35)(H,36,37);1-19H;1-8H3;4,6-8H,3,5H2,1-2H3;1-6H,13H2,(H2,14,15);7*1H4.
What are the key properties of 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane has a molecular weight of 3625.53 g/mol, XLogP of 48.95, 42 rotatable bonds, 8 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(5-bromo-3-pyridinyl)-4-methylpentan-2-one;5-bromo-1-tritylindazole-3-carbaldehyde;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1-tritylindazol-5-yl]-3-pyridinyl]-3-methylbutanamide;5-(3-fluorophenyl)pyridine-3,4-diamine;N-[5-(3-formyl-1-tritylindazol-5-yl)-3-pyridinyl]-3-methylbutanamide;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylindazole-3-carbaldehyde;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is sourced from PubChem (CID 161415040), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).